Panniculitis: Workup and Treatment
For patients with suspected panniculitis, obtain a deep excisional skin biopsy reaching the subcutaneous fat (not a superficial punch biopsy) and immediately check alpha-1 antitrypsin (AAT) levels, as AAT deficiency-associated panniculitis requires specific augmentation therapy that can be life-saving.
Diagnostic Workup
Essential Initial Testing
The diagnostic approach must prioritize identifying life-threatening causes:
Deep excisional biopsy: Required for adequate tissue sampling of subcutaneous fat, septa, and lobules 1. Superficial punch biopsies are inadequate and miss critical diagnostic features.
Alpha-1 antitrypsin level and phenotyping: Mandatory in all cases of severe or necrotizing panniculitis 1. AAT deficiency-associated panniculitis can be lethal and requires specific treatment.
Microbiological cultures: Submit biopsy tissue for bacterial, fungal, and mycobacterial cultures to exclude infectious causes 2.
Clinical Pattern Recognition
Identify the clinical presentation pattern:
- Location: Thighs/buttocks suggest AAT deficiency; lower extremities suggest erythema nodosum or pancreatic panniculitis
- Ulceration: Spontaneous ulceration with drainage of clear, yellow, oily fluid is pathognomonic for AAT deficiency 1
- Trauma history: Present in one-third of AAT deficiency cases 1
- Age: Mean age 40 years for AAT deficiency panniculitis 1
Additional Targeted Testing
Based on clinical suspicion:
- Pancreatic enzymes (lipase, amylase): For pancreatic panniculitis, even without abdominal pain 3
- Vasculitis workup: If livedo racemosa or systemic symptoms present, consider polyarteritis nodosa evaluation 4, 5
- Autoimmune serologies: ANA, anti-dsDNA for lupus panniculitis
- Sarcoidosis evaluation: ACE level, chest imaging if systemic features present
Treatment Approach
AAT Deficiency-Associated Panniculitis (Priority)
This is the most critical diagnosis to identify due to specific effective therapy:
- Augmentation therapy with purified human AAT or fresh frozen plasma is the definitive treatment to restore plasma and tissue AAT levels 1
- Dapsone: Either alone in less severe cases or combined with augmentation therapy 1
- Avoid: Corticosteroids, antibiotics, and cytostatic drugs are useless 1
- Smoking cessation: Essential, as smoking worsens AAT function 1
- Family screening: Mandatory given genetic inheritance 1
Vasculitis-Associated Panniculitis
If polyarteritis nodosa is confirmed:
- Severe disease: Cyclophosphamide plus high-dose glucocorticoids (prednisone 1 mg/kg/day) 4, 5
- Non-severe disease: Non-glucocorticoid immunosuppressive agents (methotrexate, azathioprine) plus moderate-dose glucocorticoids 4, 5
- Physical therapy: Conditionally recommended for nerve/muscle involvement 4
Other Specific Panniculitides
Treatment depends on underlying cause identified:
- Pancreatic panniculitis: Treat underlying pancreatic disease; supportive care for skin lesions
- Lupus panniculitis: Systemic immunosuppression with antimalarials, corticosteroids, immunosuppressives
- Erythema nodosum: Identify and treat underlying cause; NSAIDs for symptomatic relief
Critical Pitfalls to Avoid
Superficial biopsy: Will miss diagnostic features and delay appropriate treatment 1
Assuming all panniculitis responds to steroids: AAT deficiency panniculitis does NOT respond to corticosteroids and requires augmentation therapy 1
Missing AAT deficiency: Check AAT levels in ALL cases of severe, necrotizing, or ulcerative panniculitis 1. The WHO recommends analyzing plasma AAT levels in all biopsy-proven severe panniculitis cases 1
Delaying treatment in AAT deficiency: This condition can be lethal; early augmentation therapy is critical 1
Ignoring pancreatic disease: Pancreatic panniculitis can occur without abdominal pain 3; check pancreatic enzymes routinely
Inadequate tissue for pathology: Deep excisional specimens with large amounts of tissue are required, not punch biopsies 1